<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Fresenius USA, Inc., et al.; Withdrawal of Approval of 216 Abbreviated New Drug Applications; Correction</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Fresenius USA, Inc., et al.; Withdrawal of Approval of 216 Abbreviated New Drug Applications; Correction</h1>
    <p class="timestamp">Published: 2022-01-18 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of October 22, 2021. The document announced the withdrawal of approval of 216 abbreviated new drug applications (ANDAs) from multiple applicants, as of November 22, 2021. The document was published with an incorrect date. In addition, the document indicated that FDA was withdrawing approval of ANDA 075941, Strontium Chloride SR-89 Injection, 1 millicurie/milliliter, held by Bio-Nucleonics, Inc., 1...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2022-00831</p>
    <p><strong>Publication Date:</strong> 2022-01-18</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2022/01/18/2022-00831/fresenius-usa-inc-et-al-withdrawal-of-approval-of-216-abbreviated-new-drug-applications-correction">https://www.federalregister.gov/documents/2022/01/18/2022-00831/fresenius-usa-inc-et-al-withdrawal-of-approval-of-216-abbreviated-new-drug-applications-correction</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2022-00831</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
